Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy.

Gribben, J G; Goldstone, A H; Linch, D C; Taghipour, G; McMillan, A K; Souhami, R L; Earl, H; Richards, J D

Gribben, J G; Goldstone, A H; Linch, D C; Taghipour, G; McMillan, A K; Souhami, R L; Earl, H; Richards, J D.

Affiliation

Gribben JG; Department of Haematology, University College, London, England.

J Clin Oncol ; 7(11): 1621-9, 1989 Nov.

Article in En | MEDLINE | ID: mdl-2809678

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Bone Marrow Transplantation; Lymphoma, Non-Hodgkin/therapy; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bone Marrow/pathology; Dose-Response Relationship, Drug; Female; Humans; Lymphoma, Non-Hodgkin/pathology; Male; Middle Aged; Prognosis; Sex Factors; Survival Rate; Transplantation, Autologous

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Bone Marrow Transplantation Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1989 Type: Article Affiliation country: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links